CGEM CIK: 1789972

Cullinan Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−43.4
FY22:
−127
FY23:
−134
FY24:
−145
FY25:
−176
Change from FY21 to FY25
millions USD
FY21:
−334
FY22:
249
FY23:
35.8
FY24:
−136
FY25:
180
Change from FY21 to FY25
millions USD
FY21:
269
FY22:
−25.9
FY23:
40.8
FY24:
266
FY25:
1.09
(positive)
Change from FY21 to FY25
millions USD
FY21:
−43.4
FY22:
−128
FY23:
−134
FY24:
−145
FY25:
−176

All amounts in millions USD Data source:SEC EDGAR